Cargando…
Injectable niclosamide nanohybrid as an anti-SARS-CoV-2 strategy
COVID-19 is a rapidly evolving emergency, which necessitates scientific community to come up with novel formulations that could find quick relief to the millions affected around the globe. Remdesivir being the only injectable drug by FDA for COVID-19, it initially showed promising results, however,...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier B.V.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8383483/ https://www.ncbi.nlm.nih.gov/pubmed/34482191 http://dx.doi.org/10.1016/j.colsurfb.2021.112063 |